Journal article
124 Phase II Randomized Trial of Optimal Recurrence-Directed Therapy (RDT) Without or with Androgen-Deprivation Therapy (ADT) in Radio-Recurrent Oligo-Metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC): The OCOG-Rational-PCS Trial
Authors
Gouveia A; Vavassis P; Mesci A; Hotte S; Berlin A; Zukotynski K; Morgan S; Dayes I; Perlis N; Wright J
Journal
Radiotherapy and Oncology, Vol. 198, , pp. s54–s55
Publisher
Elsevier
Publication Date
September 1, 2024
DOI
10.1016/s0167-8140(24)03611-9
ISSN
0167-8140
